The yellow vertical line is the line of identity (1.0 hazard ratio)if the 95% confidence intervals crosses it, that specific outcome is not statistically significant
A meta-analysis of 45 randomized controlled trials observed a trend toward increased risk of thyroid dysfunction in patients treated with GLP-1 receptor agonists, although the findings did not reach statistical significance
Tirzepatide and Covid-19 TZT improves ED and associated inflammatory changes through the modulation of glucose homeostasis, insulin sensitivity, and release of pro-inflammatory biomarkers
Non-oral methods are not affected
For patients taking semaglutide who have not achieved desired weight loss, ensuring adequate dose titration to the maximum tolerated dose (2.4 mg weekly for Wegovy) and allowing sufficient treatment duration (at least 16-20 weeks) is essential before adding additional pharmacotherapy
Amycretin: The Oral Obesity Pill That Could Change Everything About Access to Metabolic Medicine What if effective obesity treatment didnt require an injection